F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comAlkyl Amines Chemicals Limited is one of India’s leading specialty chemical companies, known for manufacturing aliphatic amines, specialty amines, and derivatives used across pharmaceuticals, agrochemicals, rubber chemicals, water treatment, and personal care industries. With a strong promoter holding and a solid position in niche chemical segments, the company has remained a long-term favorite among high-quality mid-cap chemical stocks. In this article, we analyze Alkyl Amines Chemicals Ltd share price target from 2025 to 2030, along with its current market performance and long-term outlook.
Let’s take a closer look at Alkyl Amines’ business fundamentals, shareholding pattern, and future price targets.
| Detail | Value |
|---|---|
| Current Price | ₹1,653.00 |
| Previous Close | ₹1,658.40 |
| Day’s High | ₹1,661.30 |
| Day’s Low | ₹1,625.00 |
| 52-Week High | ₹2,438.80 |
| 52-Week Low | ₹1,508.00 |
| Market Capitalization | ₹8,374 Cr |
| Volume | 20,193 |
| Value (Lacs) | ₹330.64 |
| VWAP | ₹1,640.25 |
| Beta | 1.19 |
| Upper Circuit | ₹1,990.00 |
| Lower Circuit | ₹1,326.80 |
| Face Value | ₹2 |
| All-Time High | ₹4,749.00 |
| All-Time Low | ₹0.84 |
The stock is currently trading well below its all-time high, indicating a consolidation phase after a prolonged growth cycle.
Alkyl Amines Chemicals Limited is a pioneer in the Indian specialty chemicals space with decades of manufacturing expertise. The company supplies its products to global and domestic markets, serving customers in pharmaceuticals, dyes, water treatment chemicals, agrochemicals, and other industrial applications.
With a strong focus on capacity expansion, process innovation, and backward integration, Alkyl Amines has built sustainable competitive advantages and maintained healthy margins over multiple business cycles.
Leadership position in aliphatic amines and derivatives
Strong export presence serving global customers
Backward integration ensuring cost efficiency
Consistent focus on capacity expansion
Strong balance sheet and cash generation
| Investor Type | Holding (%) |
|---|---|
| Promoters | 72.03% |
| Retail & Others | 21.66% |
| Foreign Institutions | 3.43% |
| Other Domestic Institutions | 1.48% |
| Mutual Funds | 1.41% |
The very high promoter holding reflects strong promoter conviction and long-term commitment to the business.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | 1,750 | 1,900 |
| 2026 | 1,950 | 2,150 |
| 2027 | 2,200 | 2,450 |
| 2028 | 2,600 | 2,900 |
| 2029 | 3,000 | 3,350 |
| 2030 | 3,600 | 4,000 |
These targets are estimated considering demand growth in specialty chemicals, expansion benefits, global market opportunities, and overall sector outlook.
By 2025, Alkyl Amines is expected to regain steady growth momentum after recent price correction.
Why 2025 may be stable:
Improved demand from pharma and agrochemical sectors
New capacities contributing to revenue
Better cost control and margin stability
Investment Outlook: Suitable for gradual accumulation with a long-term horizon.
In 2026, earnings growth may accelerate with rising utilization levels.
Key growth drivers:
Increasing exports to regulated markets
Higher contribution from value-added products
Strong operating leverage
Investment Outlook: Hold strategy recommended for long-term investors.
By 2027, Alkyl Amines could benefit from strong global chemicals demand.
Why growth may continue:
Expansion into specialty amine derivatives
Stable raw material sourcing
Improving return on capital employed
Investment Outlook: Positive phase for steady compounding.
In 2028, the company may strengthen its leadership in niche segments.
Growth factors:
Sustained demand from pharmaceuticals and personal care
Higher pricing power due to specialized offerings
Strong free cash flow generation
Investment Outlook: Long-term investors may see meaningful portfolio growth.
By 2029, Alkyl Amines could be among the most stable specialty chemical players in India.
Why this level is realistic:
Consistent earnings visibility
Strong promoter-led execution
Favorable global chemical supply chain shifts
Investment Outlook: Suitable for investors seeking quality and stability.
By 2030, Alkyl Amines may significantly expand its global footprint.
Long-term positives:
Strong niche positioning
Continuous capacity additions
High entry barriers in specialty chemicals
Investment Outlook: Attractive for long-term wealth creation with moderate risk.
Alkyl Amines Chemicals Limited is considered a high-quality specialty chemical company with strong fundamentals and experienced management. Its diversified end-use industries provide stability across economic cycles.
High promoter holding and long-term vision
Strong export growth potential
Leadership in niche chemical products
Healthy balance sheet and cash flows
Cyclicality in global chemical demand
Raw material price volatility
Regulatory and environmental compliance risks
Investors should balance growth potential with these risks.
Alkyl Amines Chemicals Limited remains one of the strongest names in India’s specialty chemicals sector. Currently trading around ₹1,653, the stock is well below its historical peak, offering potential long-term opportunity for patient investors. Based on industry trends and business fundamentals, the stock has the potential to reach ₹3,600 to ₹4,000 by 2030.
For investors looking to benefit from India’s growing presence in global specialty chemicals, Alkyl Amines Chemicals Ltd can be a solid long-term investment choice.
The estimated share price target for 2025 is between ₹1,750 and ₹1,900.
Yes, due to strong fundamentals, niche products, and high promoter holding, it is considered suitable for long-term investors.
The expected share price target for 2030 ranges between ₹3,600 and ₹4,000, based on current growth assumptions.
Promoters hold approximately 72.03% of the company’s shares.
Its products are used in pharmaceuticals, agrochemicals, rubber chemicals, personal care, and water treatment sectors.
Disclaimer: This article is for educational purposes only and does not constitute investment advice. Please consult a qualified financial advisor before making any investment decisions.
Register & Login